HRSA-22-068: Regional Hemophilia Network
Closed
This grant is closed. A newer notice from the same program is open now: Women's Initiative for Screening and Health (WISH) (HRSA-27-072). Status: Closes January 8, 2027 (62 days left). It is in our archive of Health Resources and Services Administration notices from 2021.
Health Resources and Services Administration offered grants to the applicants described in the notice. It expected to make about 8 awards worth $4.0 million in total. Applications closed on January 24, 2022.
From the official notice on Grants.gov, last changed October 26, 2021. Checked November 7, 2026.
- Total funding$4.0 million
- Expected awards8
- Cost sharingNot required
- Funding typeGrant
Key dates
| Posted | October 26, 2021 |
|---|---|
| Deadline | January 24, 2022 |
| Archived by Grants.gov | March 25, 2022 |
Who can apply
This opportunity was open to the applicants described in the notice.
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
Eligible applicants for both funding opportunities include any domestic public or private entity, including an Indian tribe or tribal organization (as those terms are defined at 25 U.S.C. § 450b).See 42 CFR § 51a.3(a). Domestic faith-based and community-based organizations are eligible to apply.
Is this a realistic fit?
- No cost sharing or match is required.
What the grant funds
The goal of HRSA-22-068 is to establish regional networks of hemophilia treatment centers (HTCs) to improve the health and well-being for children, youth, and adults with hemophilia and related bleeding disorders and clotting disorders. HRSA will fund up to eight recipients will be funded for HRSA-22-068, one recipient per region. The eight HRSA-designated Hemophilia Regions1 are: • New England: Connecticut, Maine, Massachusetts, New Hampshire, Rhode Island, Vermont, New Jersey, New York, Puerto Rico, US Virgin Islands • Mid-Atlantic: Delaware, DC, Maryland, Pennsylvania, Virginia, West Virginia • Southeast: Alabama, Florida, Georgia, Mississippi, Kentucky, North Carolina, South Carolina, Tennessee • Great Lakes: Indiana, Michigan, Ohio • Northern States: Illinois, Minnesota, North Dakota, South Dakota, Wisconsin • Great Plains: Arkansas, Louisiana, Oklahoma, Texas, Iowa, Kansas, Missouri, Nebraska • Mountain States: Alaska, Idaho, Oregon, Washington, Arizona, Colorado, Montana, New Mexico, Utah, Wyoming • Western States and Territory: California, Hawaii, Nevada, and the Pacific Islands 1 The Hemophilia Regions are defined by HRSA using a combination of the Public Health Service Regions and similarity in numbers of patients and numbers of hemophilia treatment centers. Each recipient is expected to be responsible for identifying, establishing, and monitoring a network of HTCs in the region. In collaboration with the NHPCC, recipients are expected to provide monitoring oversight, technical assistance (TA), education, and quality improvement opportunities for HTC staff on staff development issues, best practices for disease management and evidence-informed treatment guidelines, and patient and family education.
Who has won Special Projects of Regional and National Significance grants before
From fiscal 2021 to 2025, Special Projects of Regional and National Significance (93.110) awarded $1.4 billion across 842 grant awards, an average of $1.6 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| Zero to Three National Center for Infants, Toddlers & Families | District of Columbia | 2 | $54.3 million |
| University Hospitals Cleveland Medical Center | Ohio | 1 | $51.5 million |
| Children's National Medical Center | District of Columbia | 1 | $37.2 million |
| University of North Carolina at Chapel Hill | North Carolina | 8 | $29.1 million |
| American Academy of Pediatrics | Illinois | 8 | $26.4 million |
Applying now
This notice no longer takes applications. Apply under the newer notice, HRSA-27-072, which is open now.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is HRSA-22-068 still open?
No. It closed on January 24, 2022. A newer notice is open: HRSA-27-072, closes January 8, 2027 (62 days left).
Who can apply for Regional Hemophilia Network?
Health Resources and Services Administration accepted applications from the applicants described in the notice. The notice adds further conditions, so read its eligibility section.
What is the deadline for Regional Hemophilia Network?
Closed January 24, 2022. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
About $4.0 million in total across about 8 awards.
Who has won Special Projects of Regional and National Significance grants before?
The largest recipients over five fiscal years were Zero to Three National Center for Infants, Toddlers & Families, University Hospitals Cleveland Medical Center, Children's National Medical Center. The program made 842 awards worth $1.4 billion in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)